Centaur, with a strong focus has built strengths across their formulations and exports   business. We are now strategically poised to capitalize on the emerging opportunities in the   domestic and international markets and deliver enhanced long term value.

Centaur is the 45th largest pharmaceutical company in India in prescription sales   generating more than 50 million prescriptions per year. Centaur brands are exported to over   50 countries worldwide.

An All-India network of 800 field personnel, 25 marketing offices, 1,500 authorised   stockists & 100,000 retailers ensure availability and encashment of more than a million   prescriptions generated every month by 100,000 Doctors of all specialities across India. This
endeavour is further augmented with thrust on pioneering CRM (Customer Relationship            
Management) initiative.

Centaur, over the years has demonstrated its competence in transforming products into strong brands, reinforced by successful extensions, resulting in a formidable presence in key therapeutic areas. Power brands like Sinarest, brand leader in the anti-cold segment and Ocurest, brand leader in the ophthalmic astringent market best exemplify this strategy. Prescription audits confirm that atleast one prescription of Sinarest is generated every second by a doctor somewhere in India.

Metoz (Metolazone) launched for the first time in India is on the verge of leadership under Nephrotic Syndrome Segment

We apply the finest organic, strategic design models like T6, HIP, PP, HT, GBM, AKH (Targeting Model) in our marketing operations.